529 related articles for article (PubMed ID: 24013011)
21. Nanovehicle-based Small Interfering RNA (siRNA) Delivery for Therapeutic Purposes: A New Molecular Approach in Pharmacogenomics.
Akhtari J; Tafazoli A; Mehrad-Majd H; Mahrooz A
Curr Clin Pharmacol; 2018; 13(3):173-182. PubMed ID: 29992895
[TBL] [Abstract][Full Text] [Related]
22. Multifunctional cationic lipid-based nanoparticles facilitate endosomal escape and reduction-triggered cytosolic siRNA release.
Gujrati M; Malamas A; Shin T; Jin E; Sun Y; Lu ZR
Mol Pharm; 2014 Aug; 11(8):2734-44. PubMed ID: 25020033
[TBL] [Abstract][Full Text] [Related]
23. Multifunctional PEI-entrapped gold nanoparticles enable efficient delivery of therapeutic siRNA into glioblastoma cells.
Kong L; Qiu J; Sun W; Yang J; Shen M; Wang L; Shi X
Biomater Sci; 2017 Jan; 5(2):258-266. PubMed ID: 27921110
[TBL] [Abstract][Full Text] [Related]
24. Nano-scale delivery systems for siRNA delivery in cancer therapy: New era of gene therapy empowered by nanotechnology.
Ebrahimi N; Manavi MS; Nazari A; Momayezi A; Faghihkhorasani F; Rasool Riyadh Abdulwahid AH; Rezaei-Tazangi F; Kavei M; Rezaei R; Mobarak H; Aref AR; Fang W
Environ Res; 2023 Dec; 239(Pt 2):117263. PubMed ID: 37797672
[TBL] [Abstract][Full Text] [Related]
25. Nanotechnology for in vivo targeted siRNA delivery.
Dahlman JE; Kauffman KJ; Langer R; Anderson DG
Adv Genet; 2014; 88():37-69. PubMed ID: 25409603
[TBL] [Abstract][Full Text] [Related]
26. Overcoming the Challenges of siRNA Delivery: Nanoparticle Strategies.
Shajari N; Mansoori B; Davudian S; Mohammadi A; Baradaran B
Curr Drug Deliv; 2017; 14(1):36-46. PubMed ID: 27538460
[TBL] [Abstract][Full Text] [Related]
27. Targeted decationized polyplexes for siRNA delivery.
Novo L; Takeda KM; Petteta T; Dakwar GR; van den Dikkenberg JB; Remaut K; Braeckmans K; van Nostrum CF; Mastrobattista E; Hennink WE
Mol Pharm; 2015 Jan; 12(1):150-61. PubMed ID: 25384057
[TBL] [Abstract][Full Text] [Related]
28. siRNA-Conjugated Nanoparticles to Treat Ovarian Cancer.
Halbur C; Choudhury N; Chen M; Kim JH; Chung EJ
SLAS Technol; 2019 Apr; 24(2):137-150. PubMed ID: 30616494
[TBL] [Abstract][Full Text] [Related]
29. Bio-inspired materials in drug delivery: Exploring the role of pulmonary surfactant in siRNA inhalation therapy.
De Backer L; Cerrada A; PĂ©rez-Gil J; De Smedt SC; Raemdonck K
J Control Release; 2015 Dec; 220(Pt B):642-50. PubMed ID: 26363301
[TBL] [Abstract][Full Text] [Related]
30. Quantum rods as nanocarriers of gene therapy.
Aalinkeel R; Nair B; Reynolds JL; Sykes DE; Law WC; Mahajan SD; Prasad PN; Schwartz SA
Drug Deliv; 2012 May; 19(4):220-31. PubMed ID: 22643056
[TBL] [Abstract][Full Text] [Related]
31. Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles.
Shahzad MM; Mangala LS; Han HD; Lu C; Bottsford-Miller J; Nishimura M; Mora EM; Lee JW; Stone RL; Pecot CV; Thanapprapasr D; Roh JW; Gaur P; Nair MP; Park YY; Sabnis N; Deavers MT; Lee JS; Ellis LM; Lopez-Berestein G; McConathy WJ; Prokai L; Lacko AG; Sood AK
Neoplasia; 2011 Apr; 13(4):309-19. PubMed ID: 21472135
[TBL] [Abstract][Full Text] [Related]
32. Recent advances in nanoparticle-mediated siRNA delivery.
Williford JM; Wu J; Ren Y; Archang MM; Leong KW; Mao HQ
Annu Rev Biomed Eng; 2014 Jul; 16():347-70. PubMed ID: 24905873
[TBL] [Abstract][Full Text] [Related]
33. Multifunctional nanocarrier based on clay nanotubes for efficient intracellular siRNA delivery and gene silencing.
Wu H; Shi Y; Huang C; Zhang Y; Wu J; Shen H; Jia N
J Biomater Appl; 2014 Apr; 28(8):1180-9. PubMed ID: 23985535
[TBL] [Abstract][Full Text] [Related]
34. Lipid-based nanoparticles in the systemic delivery of siRNA.
Lin Q; Chen J; Zhang Z; Zheng G
Nanomedicine (Lond); 2014 Jan; 9(1):105-20. PubMed ID: 24354813
[TBL] [Abstract][Full Text] [Related]
35. siRNA delivery using nanocarriers - an efficient tool for gene silencing.
Khurana B; Goyal AK; Budhiraja A; Arora D; Vyas SP
Curr Gene Ther; 2010 Apr; 10(2):139-55. PubMed ID: 20353386
[TBL] [Abstract][Full Text] [Related]
36. Systemic delivery of siRNA via LCP nanoparticle efficiently inhibits lung metastasis.
Yang Y; Li J; Liu F; Huang L
Mol Ther; 2012 Mar; 20(3):609-15. PubMed ID: 22186791
[TBL] [Abstract][Full Text] [Related]
37. Nanoengineered strategies for siRNA delivery: from target assessment to cancer therapeutic efficacy.
Mishra DK; Balekar N; Mishra PK
Drug Deliv Transl Res; 2017 Apr; 7(2):346-358. PubMed ID: 28050890
[TBL] [Abstract][Full Text] [Related]
38. Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.
Gandhi NS; Tekade RK; Chougule MB
J Control Release; 2014 Nov; 194():238-56. PubMed ID: 25204288
[TBL] [Abstract][Full Text] [Related]
39. Progress and perspective of inorganic nanoparticle-based siRNA delivery systems.
Jiang Y; Huo S; Hardie J; Liang XJ; Rotello VM
Expert Opin Drug Deliv; 2016; 13(4):547-59. PubMed ID: 26735861
[TBL] [Abstract][Full Text] [Related]
40. Nanodelivery systems for nucleic acid therapeutics in drug resistant tumors.
Iyer AK; Duan Z; Amiji MM
Mol Pharm; 2014 Aug; 11(8):2511-26. PubMed ID: 24661041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]